AMA House to Consider Resolution on Use of Antipsychotics for Dementia
Use of antipsychotic medications for patients with dementia in long-term care facilities will be among the issues discussed over the next three days by physicians gathering today for the interim policymaking meeting of the American Medical Association’s House of Delegates in New Orleans. (Pictured is psychiatrist Jeremy Lazarus, M.D., who was elected president-elect of the AMA in June; Lazarus will begin his tenure as president in June 2012.) See upcoming editions of Psychiatric News for coverage of the meeting; for reports on the use of antipsychotics to treat dementia, see http://psychnews.psychiatryonline.org/newsarticle.aspx?articleid=108443, and http://psychnews.psychiatryonline.org/newsArticle.aspx?articleid=115824.
The content of Psychiatric News does not necessarily reflect the views of APA or the editors. Unless so stated, neither Psychiatric News nor APA guarantees, warrants, or endorses information or advertising on this site. Clinical information is not peer reviewed and thus should be independently verified.